Hot Pursuit     12-Jul-24
Biocon Ltd eases for fifth straight session
Biocon Ltd is quoting at Rs 350.65, down 1.1% on the day as on 13:19 IST on the NSE. The stock jumped 36.36% in last one year as compared to a 26.47% rally in NIFTY and a 48.35% spurt in the Nifty Pharma index.

Biocon Ltd dropped for a fifth straight session today. The stock is quoting at Rs 350.65, down 1.1% on the day as on 13:19 IST on the NSE. The benchmark NIFTY is up around 0.98% on the day, quoting at 24553.1. The Sensex is at 80676.48, up 0.98%.Biocon Ltd has gained around 3.7% in last one month.Meanwhile, Nifty Pharma index of which Biocon Ltd is a constituent, has increased around 3.77% in last one month and is currently quoting at 20601.7, down 0.07% on the day. The volume in the stock stood at 28.06 lakh shares today, compared to the daily average of 57.18 lakh shares in last one month.

The benchmark July futures contract for the stock is quoting at Rs 351.5, down 1.31% on the day. Biocon Ltd jumped 36.36% in last one year as compared to a 26.47% rally in NIFTY and a 48.35% spurt in the Nifty Pharma index.

The PE of the stock is 393.72 based on TTM earnings ending March 24.

Previous News
  Barometers pares all gains ; realty shares decline
 ( Market Commentary - Mid-Session 24-May-24   10:36 )
  Biocon
 ( Results - Analysis 17-May-24   10:41 )
  Benchmarks trade falt; oil & gas shares rally for 9th day in row
 ( Market Commentary - Mid-Session 24-May-24   12:33 )
  Biocon Ltd spurts 1.22%, gains for third straight session
 ( Hot Pursuit - 07-Jun-24   13:05 )
  Biocon gets US FDA approval for market generic version of anti-cancer drug
 ( Hot Pursuit - 07-Feb-24   09:35 )
  Biocon gains after receiving MHRA UK approval for Liraglutide injection
 ( Hot Pursuit - 01-Apr-24   10:34 )
  Biocon surges after signing exclusive licensing deal for Liraglutide with Handok
 ( Hot Pursuit - 24-May-24   09:45 )
  Biocon's API unit in Bangalore receives GMP compliance certificate
 ( Corporate News - 08-Jun-23   16:30 )
  Biocon's subsidiary receives UK’s MHRA approval for Aflibercept biosimilar
 ( Hot Pursuit - 13-Nov-23   17:05 )
  Biocon's Malaysia facility gets OAI status from USFDA
 ( Hot Pursuit - 18-Oct-23   08:42 )
  Eris Lifesciences avails term loan of Rs 280 cr from Citi Bank
 ( Corporate News - 09-Nov-23   09:15 )
Other Stories
  Shree Cement Q1 PAT drops 45% YoY to Rs 318 cr
  06-Aug-24   16:59
  Graphite India gains on reporting turnaround Q1 results
  06-Aug-24   16:41
  Vedanta Q1 PAT jumps 54% YoY to Rs 5,095 cr
  06-Aug-24   16:11
  PFC Q1 PAT jumps 20% YoY to Rs 7,182 cr
  06-Aug-24   15:51
  Symphony hits 52-week high after Q1 PAT soars YoY Rs 88 cr; Board OKs buyback upto Rs 71.40 cr
  06-Aug-24   15:09
  Shivalik Bimetal Controls Ltd leads losers in 'A' group
  06-Aug-24   15:00
  TVS Motor Q1 PAT climbs 23% YoY to Rs 577 crore
  06-Aug-24   14:46
  Indian Terrain Fashions Ltd leads losers in 'B' group
  06-Aug-24   14:45
  Volumes soar at K P R Mill Ltd counter
  06-Aug-24   14:30
  Triveni Turbine spurts as Q1 PAT climbs 32% YoY to Rs 80 cr
  06-Aug-24   14:06
Back Top